Asker Healthcare Group AB (publ) (STO:ASKER)
Sweden · Delayed Price · Currency is SEK 59.35
-0.65 (-1.08%)
Sep 18, 2026, 5:29 PM CET
Asker Healthcare Group AB Ratios and Metrics
Market cap in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 22,733 | 32,328 | - | - | - | - | |
Market Cap Growth | -35.56% | - | - | - | - | - |
Enterprise Value | 28,473 | 36,908 | - | - | - | - |
Last Close Price | 59.35 | 83.99 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.80 | 65.71 | - | - | - | - |
Forward PE | 18.79 | 28.98 | - | - | - | - |
PS Ratio | 1.26 | 1.93 | - | - | - | - |
PB Ratio | 3.24 | 4.91 | - | - | - | - |
P/FCF Ratio | 22.85 | 43.81 | - | - | - | - |
P/OCF Ratio | 14.97 | 24.34 | - | - | - | - |
PEG Ratio | 1.04 | 1.45 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.58 | 2.20 | - | - | - | - |
EV/EBITDA Ratio | 13.15 | 23.66 | - | - | - | - |
EV/EBIT Ratio | 22.54 | 33.77 | - | - | - | - |
EV/FCF Ratio | 28.62 | 50.01 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.92 | 0.88 | 1.70 | 1.64 | 1.70 | 2.16 |
Debt / EBITDA Ratio | 2.99 | 3.15 | 3.75 | 4.35 | 4.50 | 4.97 |
Debt / FCF Ratio | 6.51 | 7.88 | 6.78 | 5.52 | 5.56 | 15.22 |
Net Debt / Equity Ratio | 0.81 | 0.75 | 1.56 | 1.51 | 1.62 | 1.89 |
Net Debt / EBITDA Ratio | 3.03 | 3.16 | 4.05 | 4.91 | 5.06 | 5.12 |
Net Debt / FCF Ratio | 5.73 | 6.68 | 6.22 | 5.09 | 5.31 | 13.31 |
Asset Turnover | 1.09 | 1.12 | 1.23 | 1.25 | 1.33 | - |
Inventory Turnover | 4.91 | 5.14 | 5.61 | 6.25 | 6.26 | - |
Quick Ratio | 0.77 | 0.82 | 0.79 | 0.84 | 0.84 | 1.04 |
Current Ratio | 1.31 | 1.36 | 1.40 | 1.40 | 1.53 | 1.76 |
Return on Equity (ROE) | 10.49% | 10.11% | 11.46% | 7.03% | 18.82% | - |
Return on Assets (ROA) | 4.78% | 4.57% | 5.33% | 3.71% | 5.07% | - |
Return on Invested Capital (ROIC) | 8.07% | 8.26% | 8.44% | 5.70% | 8.77% | 9.95% |
Return on Capital Employed (ROCE) | 9.40% | 8.60% | 10.50% | 7.60% | 8.90% | 10.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.15% | 1.52% | - | - | - | - |
FCF Yield | 4.38% | 2.28% | - | - | - | - |
Dividend Yield | 0.66% | 0.46% | - | - | - | - |
Buyback Yield / Dilution | -13.57% | -14.59% | -22.56% | -1.55% | -9.55% | - |
Total Shareholder Return | -12.92% | -14.13% | -22.56% | -1.55% | -9.55% | - |